BSEEverest Organics Ltd· Pharmaceuticals & BiotechnologyHighNeutral
Announced Wed, 17 Dec, 2025 · 17:34 IST

Submission of voting results for the postal ballot (E voting).

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-4.0%Reaction day
₹480.00
prior close
—
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used-0.3%-3.6% vs market
Pharmaceuticals peers, median of 152sector-0.4%-3.5% vs sector

On the reaction day the stock moved 3.6 pts less than Nifty Microcap 250 and 3.5 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
—
10m
—
15m
—
30m
—
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-4.0-0.3-3.6-0.4-3.5
Next day
-5.8+0.9-6.8+0.6-6.4
2d
-3.8+2.3-6.1+1.0-4.8
3d
-5.8+2.4-8.2+1.1-7.0
4d
-0.7+1.8-2.5+1.0-1.6
5d
-3.4+1.3-4.6+0.6-3.9
1w
+2.1+0.4+1.6-0.3+2.3
15d
+2.1-1.1+3.2-0.4+2.5
1m
-10.0-3.3-6.7-2.6-7.4
2m
-21.5-0.5-21.0-2.4-19.1
3m
-40.2-8.2-32.0-8.9-31.3
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 152Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Everest Organics Limited announced the results of a postal ballot (via remote e-voting) conducted from November 17 to December 16, 2025. Three special resolutions were passed with overwhelming shareholder approval of 99.99% (743,535 votes in favour vs. just 57 against). The resolutions approved: (1) the appointment of Mr. Venkata Satya Subbarao Pachigolla (DIN: 08363668) as a new Whole-Time Director (Executive Director) effective November 12, 2025; (2) the re-designation of Mr. Kirankumar Rampally from Non-Executive Non-Independent to Non-Executive Independent Director; and (3) the re-designation of Mr. Prasad Venkata Satya Sundara Srikakolapu from Non-Executive Independent to Non-Executive Non-Independent Director. Only 7.66% of outstanding shares were polled, with the promoter group (holding ~60% of shares) abstaining from voting.

Likely market impact

A new Executive Director joins the management team, which may strengthen operational leadership, while the re-designation of one director from Independent to Non-Independent reduces the number of independent directors on the board — something minority shareholders should monitor for governance implications.